Inhibiting citrullination in rheumatoid arthritis: Taking fuel from the fire

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Fisher, Benjamin A C ^a   Venables, Patrick J ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI CITRULLINATED PROTEIN ANTIBODY; GLUCOCORTICOID; PACLITAXEL; PEPTIDE ANTIBODY; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; CITRULLINE;

ANTIBODY SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNITY; CITRULLINATION; EDITORIAL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MEDICAL LITERATURE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; SYNOVITIS; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; NOTE; SYNOVIUM;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CITRULLINE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; SYNOVIAL MEMBRANE;

EID: 84857654534     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3740     Document Type: Editorial

References (11)

1. Makrygiannakis D, Revu S, Engström M, af Klint E, Nicholas AP, Pruijn GJM, Catrina AI. Local administration of glucocorticoids decrease synovial citrullination in rheumatoid arthritis. Arthritis Res Ther 2012, 14:R20. 10.1186/ar3702, 22284820.
2. Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008, 26:651-675. 10.1146/annurev.immunol.26.021607.090244, 18173373.
3. Brahn E, Tang C, Banquerigo ML. Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum 1994, 37:839-845. 10.1002/art.1780370611, 7911665.
4. Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR, Holers VM. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 2011, 186:4396-4404. 10.4049/jimmunol.1001620, 21346230.
5. Mangat P, Wegner N, Venables PJ, Potempa J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?. Arthritis Res Ther 2010, 12:209. 10.1186/ar3185, 2911857, 20553633.
6. Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin MC, Vincent C, Nachat R, Yamada M, Takahara H, Simon M, Guerrin M, Serre G. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007, 56:3541-3553. 10.1002/art.22983, 17968929.
7. Andrade F, Darrah E, Gucek M, Cole RN, Rosen A, Zhu X. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum 2010, 62:1630-1640. 10.1002/art.27439, 2951335, 20201080.
8. Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, Barrera P, Zendman AJ, van Venrooij WJ. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004, 63:373-381. 10.1136/ard.2003.012211, 1754951, 15020330.
9. Kinloch A, Lundberg K, Wait R, Wegner N, Lim NH, Zendman AJ, Saxne T, Malmström V, Venables PJ. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008, 58:2287-2295. 10.1002/art.23618, 18668562.
10. Darrah E, Rosen A, Giles JT, Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012, 71:92-98. 10.1136/ard.2011.151712, 21859690.
11. Vossenaar ER, van Venrooij WJ. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 2004, 6:107-111. 10.1186/ar1184, 416453, 15142259.